BIOMAT Database Logo BIOMAT Database Logo

Review: angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers prevent type 2 diabetes. 2006

Raj Padwal
University of Alberta, Edmonton, Alberta, Canada.

UI MeSH Term Description Entries

Related Publications

Raj Padwal
Review: Angiotensin converting enzyme inhibitors and angiotensin receptor blockers prevent atrial fibrillation.
February 2006, Evidence-based medicine,
Raj Padwal
Angiotensin converting enzyme inhibitors or angiotensin receptor blockers in nephropathy from type 2 diabetes.
June 2002, Current hypertension reports,
Raj Padwal
Do angiotensin converting enzyme inhibitors or angiotensin receptor blockers prevent diabetes mellitus? A meta-analysis.
January 2010, Cardiology journal,
Raj Padwal
[Angiotensin converting enzyme inhibitors and angiotensin II type 1 receptor blockers].
October 2006, Nihon rinsho. Japanese journal of clinical medicine,
Raj Padwal
Angiotensin converting enzyme inhibitors and angiotensin receptor blockers.
November 2020, BJA education,
Raj Padwal
Are angiotensin-converting enzyme inhibitors and angiotensin 2 receptor blockers teratogenic?
October 2013, Diabetic medicine : a journal of the British Diabetic Association,
Raj Padwal
Angiotensin-converting enzyme inhibitors reduce albuminuria more than angiotensin receptor blockers in patients with type 2 diabetes.
January 2013, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists,
Raj Padwal
Angiotensin-Converting Enzyme Inhibitors vs. Angiotensin Receptor Blockers.
February 2015, American family physician,
Raj Padwal
Use of beta-blockers, angiotensin-converting enzyme inhibitors, and angiotensin receptor blockers to prevent atrial fibrillation.
September 2006, Current cardiology reports,
Raj Padwal
Taste disturbance by angiotensin-converting enzyme inhibitors/angiotensin-2 receptor blockers.
April 2010, Kidney international,
Copied contents to your clipboard!